Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- an article about the Supreme Court’s denial of a petition “to review a February ruling . . . that held claims of ChromaDex, Inc.’s patent on an isolated form of vitamin B3 are directed to unpatentable subject matter under Section 101”;
- an article discussing how the Federal Circuit “vacated a $4.6 million award for lost profits” in a patent case; and
- an article highlighting a recent “fight over words” at the Federal Circuit in another patent case.